Lakhani Pharma products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer - IV solutions · Rahim Yar Khan · Pakistan
Rahim Yar Khan pharmaceutical manufacturer specializing in intravenous and electrolyte solutions.
Lakhani Pharma products in Pakistan
Lakhani Pharma (Pvt.) Limited has 23 medicine presentations registered in Pakistan under 15 brands, covering 9 generic medicines. Most of its products are in Fluids & supportive care and Anti-infectives. Its brands with the most registered strengths and packs are Laksol-WFI (Water for Injection), Laksol-5 (Dextrose, Glucose anhydrous), Laksol-NS I.V (Sodium chloride) and Laksol-RL (Calcium chloride + Potassium chloride + Sodium chloride + Sodium lactate, Ringer's lactate solution). 23 products have an official DRAP price on MedInfoBase. See all 15 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Company type
- Private pharmaceutical manufacturer - IV solutions
- Address
- 86/P, Sheikh Zayed Road, Rahim Yar Khan, Pakistan
- Website
- lakhanipharma.com ↗
- Phone
- +92 334 4519519
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 88%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Lakhani Pharma (Pvt.) Limited is priced against the market
11 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| Laksol-10 | Glucose anhydrous | 100 mg/mL | IV infusion | 500ml(without Eurocap) | 110833 | PKR 120.32 | PKR 0.24/mL | No comparator |
| Laksol-25 IV | Glucose anhydrous | 250 mg | IV infusion | 25mL | 110835 | PKR 27.88 | PKR 1.12/mL | No comparator |
| Laksol-5 | Dextrose | 5% | IV infusion | 100ml(without Eurocap) | 110830 | PKR 73.37 | PKR 0.73/mL | 🔒 Pharma Pro |
| Laksol-5 | Glucose anhydrous | 50 mg/mL | IV infusion | 500ml(without Eurocap) | 110831 | PKR 111.52 | PKR 0.22/mL | No comparator |
| Laksol-5 | Dextrose | 5% | IV infusion | 1000ml(without Eurocap) | 110832 | PKR 134.99 | PKR 0.13/mL | 🔒 Pharma Pro |
| Laksol-DS | Dextrose + Sodium chloride | NaCl 0.9g + Dextrose 5g/100 mL | IV infusion | 500ml(Without Eurocap) | 111847 | PKR 118.85 | PKR 0.24/mL | 🔒 Pharma Pro |
| Laksol-DS 1/3 | Dextrose + Sodium chloride | NaCl 0.3g + Dextrose 3.3g/100 mL | IV infusion | 500ml | 116489 | PKR 74.78 | PKR 0.15/mL | 🔒 Pharma Pro |
| Laksol-DS ½ | Dextrose + Sodium chloride | NaCl 0.45g + Dextrose 5g/100 mL | IV infusion | 500ml(Without Eurocap) | 111849 | PKR 111.52 | PKR 0.22/mL | 🔒 Pharma Pro |
| Laksol-DS 1000ml | Sodium chloride | 0.9 g | IV infusion | 1000ml(Without Eurocap) | 111848 | PKR 142.33 | PKR 0.14/mL | 🔒 Pharma Pro |
| Laksol-KCl | Potassium chloride | 7.46 % | IV infusion | 20mL x 100's | 112901 | PKR 1,555.83 | PKR 0.78/mL | No comparator |
| Laksol-Metro 100ml | Metronidazole | 500 mg | IV infusion | 100mL | 112900 | PKR 120.75 | PKR 1.21/mL | 🔒 Pharma Pro |
| Laksol-NS 1000ml | Sodium chloride | 9 mg | IV infusion | 1000ml(without Eurocap) | 110829 | PKR 129.12 | PKR 0.13/mL | No comparator |
| Laksol-NS 100ml | Sodium chloride | 9 mg | IV infusion | 100ml(without Eurocap) | 110827 | PKR 73.37 | PKR 0.73/mL | No comparator |
| Laksol-NS I.V | Sodium chloride | 9 mg | IV infusion | 25mL | 110825 | PKR 17.03 | PKR 0.68/mL | No comparator |
| Laksol-NS I.V | Sodium chloride | 9 mg/mL (0.9%) | IV infusion | 50mL | 110826 | PKR 38.70 | PKR 0.77/mL | No comparator |
| Laksol-NS I.V | Sodium chloride | 9 mg/mL | IV infusion | 500ml(without Eurocap) | 110828 | PKR 102.71 | PKR 0.21/mL | No comparator |
| Laksol-RSource observed | Calcium chloride + Potassium chloride + Sodium chloride + Sodium lactate | 0.033 g + 0.03 g + 0.860 g / 100 mL | IV infusion | 1000ml(without Eurocap) | 112053Official source ↗ | No indexed price | — | — |
| Laksol-R IV Infusion 1000ml Each 100ml contains:Calcium Chloride Dihydrate …0.033gPotassium Chloride…0.03gSodium chloride….0.860gSource observed | — | — | — | 1000ml(without Eurocap) | 112053Official source ↗ | No indexed price | — | — |
| Laksol-RL | Ringer's lactate solution | NaCl 0.6g + KCl 0.03g + CaCl2 0.02g + Na lactate 0.31g/100 mL | IV infusion | 500ml(without Eurocap) | 112054 | PKR 114.45 | PKR 0.23/mL | 🔒 Pharma Pro |
| Laksol-RL | Calcium chloride + Potassium chloride + Sodium chloride + Sodium lactate | 0.02 g + 0.03 g + 0.6 g + 0.31 g / 100 mL | IV infusion | 1000ml(without Eurocap) | 112055 | PKR 142.33 | PKR 0.14/mL | No comparator |
| Laksol-RLDSource observed | Ringer's lactate solution + Dextrose | NaCl 0.6g + KCl 0.03g + CaCl2 0.02g + Na lactate 0.31g + Dextrose 5g/100 mL | IV infusion | 500ml(without Eurocap) | 112056Official source ↗ | No indexed price | — | — |
| Laksol-RLD | Dextrose | 0.02 g + 0.03 g + 0.6 g + 0.31 g + 5 g / 100 mL | IV infusion | 1000ml(without Eurocap) | 112057 | PKR 177.55 | PKR 0.18/mL | No comparator |
| Laksol-WFI | Water for Injection | 5 mL presentation | Injection / diluent | 1's | 110822 | PKR 9.29 | PKR 9.29/vial/unit | 🔒 Pharma Pro |
| Laksol-WFI | Water for Injection | 5 mL | Injection | 100's | 110822 | PKR 808.11 | PKR 8.08/vial/unit | 🔒 Pharma Pro |
| Laksol-WFI | Water for Injection | 10 mL | Injection / diluent | 1's | 110823 | PKR 17.61 | PKR 17.61/vial/unit | 🔒 Pharma Pro |
| Laksol-WFI | Water for Injection | 20 mL presentation | Injection | 1's | 110824 | PKR 24.77 | PKR 24.77/vial/unit | No comparator |
All 15 Lakhani Pharma brands in Pakistan
- Laksol-10 Glucose anhydrous · 100 mg/mL infusion
- Laksol-25 IV Glucose anhydrous · 250 mg infusion
- Laksol-5 Dextrose, Glucose anhydrous · 5% infusion, 50 mg/mL infusion
- Laksol-DS Dextrose + Sodium chloride · NaCl 0.9g + Dextrose 5g/100 mL infusion
- Laksol-DS 1/3 Dextrose + Sodium chloride · NaCl 0.3g + Dextrose 3.3g/100 mL infusion
- Laksol-DS 1000ml Sodium chloride · 0.9 g infusion
- Laksol-DS ½ Dextrose + Sodium chloride · NaCl 0.45g + Dextrose 5g/100 mL infusion
- Laksol-KCl Potassium chloride · 7.46 % infusion
- Laksol-Metro 100ml Metronidazole · 500 mg infusion
- Laksol-NS 1000ml Sodium chloride · 9 mg infusion
- Laksol-NS 100ml Sodium chloride · 9 mg infusion
- Laksol-NS I.V Sodium chloride · 9 mg infusion, 9 mg/mL infusion, 9 mg/mL (0.9%) infusion
- Laksol-RL Calcium chloride + Potassium chloride + Sodium chloride + Sodium lactate, Ringer's lactate solution · 0.02 g + 0.03 g + 0.6 g + 0.31 g / 100 mL infusion, NaCl 0.6g + KCl 0.03g + CaCl2 0.02g + Na lactate 0.31g/100 mL infusion
- Laksol-RLD Dextrose · 0.02 g + 0.03 g + 0.6 g + 0.31 g + 5 g / 100 mL infusion
- Laksol-WFI Water for Injection · 10 mL injection, 20 mL presentation injection, 5 mL injection
Lakhani Pharma: common questions
How many products does Lakhani Pharma have in Pakistan?
Lakhani Pharma (Pvt.) Limited has 23 registered medicine presentations in Pakistan, sold under 15 brands and covering 9 generic medicines.
What are the main brands of Lakhani Pharma?
By number of registered strengths and packs, its largest brands are Laksol-WFI (Water for Injection), Laksol-5 (Dextrose, Glucose anhydrous), Laksol-NS I.V (Sodium chloride), Laksol-RL (Calcium chloride + Potassium chloride + Sodium chloride + Sodium lactate, Ringer's lactate solution) and Laksol-10 (Glucose anhydrous). This is not a sales ranking.
Which therapy areas does Lakhani Pharma cover?
The most products are in Fluids & supportive care (22) and Anti-infectives (1).
Where can I see Lakhani Pharma medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.